CHEMOMAB Granted U.S. Patent #12018074: Anti CCL24 (Eotaxin2) Antibodies for Use in the Treatment of Hepatic Diseases
CHEMOMAB Granted U.S. Patent #12018074: Anti CCL24 (Eotaxin2) Antibodies for Use in the Treatment of Hepatic Diseases
CHEMOMAB獲得美國專利#12018074:用於治療肝臟疾病的抗CCL24(Eotaxin2)抗體
CHEMOMAB Granted U.S. Patent #12018074: Anti CCL24 (Eotaxin2) Antibodies for Use in the Treatment of Hepatic Diseases
CHEMOMAB獲得美國專利#12018074:用於治療肝臟疾病的抗CCL24(Eotaxin2)抗體
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。